Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Equity

v3.20.1
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Comprehensive Income
Distributions in Excess of Accumulated Earnings
Total Stockholders’ Equity
Non- Controlling Interests
Series B Preferred Stock
Series B Preferred Stock
Preferred Stock
Series B Preferred Stock
Additional Paid-in Capital
Series B Preferred Stock
Total Stockholders’ Equity
Common Stock
Common Stock
Common Stock
Common Stock
Additional Paid-in Capital
Common Stock
Total Stockholders’ Equity
Beginning balance, preferred stock (in shares) at Dec. 31, 2018                 1,144,393            
Beginning balance, common stock (in shares) at Dec. 31, 2018   17,891,340                          
Beginning balance at Dec. 31, 2018 $ 181,053 $ 18 $ 202,053   $ (25,826) $ 176,246 $ 4,807   $ 1            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of stock, net (in shares)                 747,916       0    
Issuance of stock, net               $ 16,704 $ 1 $ 16,703 $ 16,704 $ (20) $ 0 $ (20) $ (20)
Redemptions of Series B Preferred Stock (in shares)                 (600)            
Redemptions of Series B Preferred Stock (13)   (13)     (13)     $ (13)            
Redemption of OP Units (in shares)   570,879                          
Redemptions of OP Units 0 $ 0 4,714     4,714 (4,714)                
Net income 108       105 105 3                
Dividends—Series B Preferred Stock (601)       (601) (601)                  
Distributions—OP Units and common stock (2,462)       (2,409) (2,409) (53)                
Adjustment to non-controlling interests resulting from changes in ownership of the Operating Partnership 0   43     43 (43)                
Ending balance, preferred stock (in shares) at Mar. 31, 2019                 1,891,709            
Ending balance, common stock (in shares) at Mar. 31, 2019   18,462,219                          
Ending balance at Mar. 31, 2019 $ 194,769 $ 18 223,480   (28,731) 194,769 0   $ 2            
Beginning balance, preferred stock (in shares) at Dec. 31, 2019               4,755,869 4,755,869            
Beginning balance, common stock (in shares) at Dec. 31, 2019 20,936,658 20,936,658                          
Beginning balance at Dec. 31, 2019 $ 278,970 $ 21 315,770 $ (390) (38,785) 276,621 2,349   $ 5            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of stock, net (in shares)                 1,229,531       409,800    
Issuance of stock, net               $ 27,116 $ 1 $ 27,115 $ 27,116 $ 5,324 $ 0 $ 5,324 $ 5,324
Redemptions of Series B Preferred Stock (in shares)                 (7,753)            
Redemptions of Series B Preferred Stock (185)   (185)     (185)     $ (185)            
Accumulated Other Comprehensive Loss (1,257)     (1,257)   (1,257)                  
Net income 3,101       3,059 3,059 42                
Dividends—Series B Preferred Stock (2,125)       (2,125) (2,125)                  
Distributions—OP Units and common stock (2,889)       (2,850) (2,850) (39)                
Adjustment to non-controlling interests resulting from changes in ownership of the Operating Partnership $ 0   (4)     (4) 4                
Ending balance, preferred stock (in shares) at Mar. 31, 2020               5,977,647 5,977,647            
Ending balance, common stock (in shares) at Mar. 31, 2020 21,346,458 21,346,458                          
Ending balance at Mar. 31, 2020 $ 308,055 $ 21 $ 348,020 $ (1,647) $ (40,701) $ 305,699 $ 2,356   $ 6